Proven Science. Empowered Solutions.
Who we are
Almatica is a privately held, US pharmaceutical company focused on the development, acquisition and commercialization of brand named pharmaceutical products. Our current product portfolio covers a wide range of therapeutic areas including: psychiatry, pain management, anti-infectives and cardiovascular related disorders.
Product catalog
Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed in the US or are in late stage development.
Meet our management
Lisa founded Almatica in 2009 and serves as the CEO. Under Lisa’s leadership, Almatica is actively pursuing the expansion of its US product portfolio through the development of its own product pipeline and through the in-licensing and acquisition of products that are either marketed in the US or are in late-stage development.
An important part of the overall growth strategy
An important part of the overall growth strategy for Almatica rests on building strong business alliances and partnerships.
Almatica is actively looking to expand of its US product portfolio through the in-licensing and acquisition of products (both in-market or in late stage development).
Patient Saving and Support
To help a patient’s ability to afford and stay on their prescribed medications, Almatica provides patient copay savings programs for several of its products.
